Averion Expands Operations to Europe
Averion Expands Operations to Europe and Names John Shillingford, PhD as President of New Wholly-Owned Subsidiary Averion GmbH
May 23, 2006, Framingham, Massachusetts, USA- Averion Inc. announced today its expansion into Europe through the creation of Averion GmbH, a new wholly-owned subsidiary based in Germany. The Company also announced the appointment of John Shillingford, PhD as President of Averion GmbH.
Averion GmbH will work to develop relationships with European clients as well as run European studies for existing North American clients. The new subsidiary will offer Averion?s full range of services including: Auditing, Biometrics, Clinical Monitoring, Clinical Project Management, Compliance and Validation, Database Development, Data Management, Data Monitoring and Clinical Endpoint Committees, Medical Monitoring, Medical Writing, Metrics Consulting, Pharmacovigilance, Program Planning/Study Design and Regulatory Consulting.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
